My laboratory concentrates on the development of new cancer treatments with an emphasis on the use of immunotherapy and monoclonal antibodies. We are capable of making new monoclonal antibodies against various cancer related targets and have recently received a patent for one such antibody. In collaboration with a number of other scientists at Fox Chase and as a result of laboratory based studies conducted here, I have developed clinical trials that are ongoing for treatment of patients with lung cancer.

My collaborations with scientists outside of Fox Chase also is an important part of what I do with the aim of bringing newer and more effective immune based treatments to the clinic. My laboratory also examines patients’ tumors to try to learn why some patients respond to specific treatment while others don’t. Discovery of new or better ways of treating cancer is an important part of my activities here.

In addition to laboratory based investigations, I am active in clinical trials. My goal is to offer my patients some of the best options that are available. I believe that clinical trials, when offered appropriately, can not only help us develop the next best treatment options but also allow my patients access to potentially new and promising drugs.

In addition I am actively involved in lung cancer screening and research involving potential preventative measures with the hope of detecting lung cancer early and preventing recurrences of this disease.